California Public Employees Retirement System’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-74,200
Closed -$1.97M 3234
2021
Q1
$1.97M Hold
74,200
﹤0.01% 2028
2020
Q4
$563K Sell
74,200
-1,500
-2% -$8.91K ﹤0.01% 2845
2020
Q3
$379K Buy
75,700
+3,200
+4% +$16.9K ﹤0.01% 2937
2020
Q2
$434K Buy
72,500
+4,200
+6% +$24.8K ﹤0.01% 2765
2020
Q1
$304K Sell
68,300
-6,587
-9% -$48.9K ﹤0.01% 2643
2019
Q4
$711K Buy
74,887
+23,887
+47% +$231K ﹤0.01% 2548
2019
Q3
$400K Buy
51,000
+9,000
+21% +$105K ﹤0.01% 2656
2019
Q2
$661K Sell
42,000
-81,000
-66% -$1.31M ﹤0.01% 2400
2019
Q1
$2.23M Sell
123,000
-1,777
-1% -$27.3K ﹤0.01% 1704
2018
Q4
$2.01M Buy
+124,777
New +$2.27M ﹤0.01% 1726

Other funds holding RUBY

California Public Employees Retirement System's RUBY Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2021, closing a stake of 74,200 shares — an estimated $1.97M sold.

California Public Employees Retirement System first reported a position in RUBY in Q4 2018 and held it in 10 quarters. The position peaked at $2.23M in Q1 2019. 108 funds tracked by Wall St. Rank hold RUBY as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Rubius Therapeutics, Inc position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 74,200 Rubius Therapeutics, Inc shares in Q2 2021, an estimated $1.97M.
  • California Public Employees Retirement System first reported a position in Rubius Therapeutics, Inc in Q4 2018 and held it in 10 quarters.
  • California Public Employees Retirement System's Rubius Therapeutics, Inc position peaked at $2.23M in Q1 2019.
  • 108 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.